Synthesis and secretion of interleukin-15 by freshly isolated human bronchial epithelial cells. 2004

Ning Ge, and Yasuhiko Nishioka, and Yoichi Nakamura, and Yoshio Okano, and Kazuo Yoneda, and Hirohisa Ogawa, and Akemi Sugita, and Hiroaki Yanagawa, and Saburo Sone
Department of Internal Medicine and Molecular Therapeutics, Course of Medical Oncology, University of Tokushima School of Medicine, Tokushima, Japan.

BACKGROUND Interleukin-15 (IL-15), which shares many functional activities of IL-2, is proposed as a potential modulator of T and natural killer (NK) cell-mediated inflammatory diseases. Since IL-15 gene is expressed in various cell types including epithelial cells, we examined how proinflammatory modulators affect IL-15 gene expression in both freshly isolated human bronchial epithelial cells (HBECs) and the human bronchial epithelial cell line BEAS-2B. METHODS HBECs were obtained from 25 patients with primary lung cancer by bronchial brushing under bronchofiberscopy. The expressions of IL-15 and its receptor were examined using reverse transcription-polymerase chain reaction (RT-PCR), Northern blot analysis and enzyme-linked immunosorbent assay. RESULTS IL-15 mRNA was constitutively expressed in the cells and was upregulated by several proinflammatory cytokines such as IL-1beta, tumor necrosis factor-alpha, interferon-gamma (IFN-gamma) and lipopolysaccharide. In addition, IFN-gamma but not other cytokines induced the synthesis and secretion of IL-15 protein. Investigation of IL-15 receptor expression using RT-PCR showed that IL-15Ralpha and IL-2Rbeta chains but not IL-2Ralpha or gamma chain were constitutively expressed in these cells. CONCLUSIONS Bronchial epithelial cells may contribute to T and NK cell-mediated airway inflammation through IL-15 production.

UI MeSH Term Description Entries
D007371 Interferon-gamma The major interferon produced by mitogenically or antigenically stimulated LYMPHOCYTES. It is structurally different from TYPE I INTERFERON and its major activity is immunoregulation. It has been implicated in the expression of CLASS II HISTOCOMPATIBILITY ANTIGENS in cells that do not normally produce them, leading to AUTOIMMUNE DISEASES. Interferon Type II,Interferon, Immune,gamma-Interferon,Interferon, gamma,Type II Interferon,Immune Interferon,Interferon, Type II
D007375 Interleukin-1 A soluble factor produced by MONOCYTES; MACROPHAGES, and other cells which activates T-lymphocytes and potentiates their response to mitogens or antigens. Interleukin-1 is a general term refers to either of the two distinct proteins, INTERLEUKIN-1ALPHA and INTERLEUKIN-1BETA. The biological effects of IL-1 include the ability to replace macrophage requirements for T-cell activation. IL-1,Lymphocyte-Activating Factor,Epidermal Cell Derived Thymocyte-Activating Factor,Interleukin I,Macrophage Cell Factor,T Helper Factor,Epidermal Cell Derived Thymocyte Activating Factor,Interleukin 1,Lymphocyte Activating Factor
D008070 Lipopolysaccharides Lipid-containing polysaccharides which are endotoxins and important group-specific antigens. They are often derived from the cell wall of gram-negative bacteria and induce immunoglobulin secretion. The lipopolysaccharide molecule consists of three parts: LIPID A, core polysaccharide, and O-specific chains (O ANTIGENS). When derived from Escherichia coli, lipopolysaccharides serve as polyclonal B-cell mitogens commonly used in laboratory immunology. (From Dorland, 28th ed) Lipopolysaccharide,Lipoglycans
D001980 Bronchi The larger air passages of the lungs arising from the terminal bifurcation of the TRACHEA. They include the largest two primary bronchi which branch out into secondary bronchi, and tertiary bronchi which extend into BRONCHIOLES and PULMONARY ALVEOLI. Primary Bronchi,Primary Bronchus,Secondary Bronchi,Secondary Bronchus,Tertiary Bronchi,Tertiary Bronchus,Bronchi, Primary,Bronchi, Secondary,Bronchi, Tertiary,Bronchus,Bronchus, Primary,Bronchus, Secondary,Bronchus, Tertiary
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D003609 Dactinomycin A compound composed of a two CYCLIC PEPTIDES attached to a phenoxazine that is derived from STREPTOMYCES parvullus. It binds to DNA and inhibits RNA synthesis (transcription), with chain elongation more sensitive than initiation, termination, or release. As a result of impaired mRNA production, protein synthesis also declines after dactinomycin therapy. (From AMA Drug Evaluations Annual, 1993, p2015) Actinomycin,Actinomycin D,Meractinomycin,Cosmegen,Cosmegen Lyovac,Lyovac-Cosmegen,Lyovac Cosmegen,Lyovac, Cosmegen,LyovacCosmegen
D004847 Epithelial Cells Cells that line the inner and outer surfaces of the body by forming cellular layers (EPITHELIUM) or masses. Epithelial cells lining the SKIN; the MOUTH; the NOSE; and the ANAL CANAL derive from ectoderm; those lining the RESPIRATORY SYSTEM and the DIGESTIVE SYSTEM derive from endoderm; others (CARDIOVASCULAR SYSTEM and LYMPHATIC SYSTEM) derive from mesoderm. Epithelial cells can be classified mainly by cell shape and function into squamous, glandular and transitional epithelial cells. Adenomatous Epithelial Cells,Columnar Glandular Epithelial Cells,Cuboidal Glandular Epithelial Cells,Glandular Epithelial Cells,Squamous Cells,Squamous Epithelial Cells,Transitional Epithelial Cells,Adenomatous Epithelial Cell,Cell, Adenomatous Epithelial,Cell, Epithelial,Cell, Glandular Epithelial,Cell, Squamous,Cell, Squamous Epithelial,Cell, Transitional Epithelial,Cells, Adenomatous Epithelial,Cells, Epithelial,Cells, Glandular Epithelial,Cells, Squamous,Cells, Squamous Epithelial,Cells, Transitional Epithelial,Epithelial Cell,Epithelial Cell, Adenomatous,Epithelial Cell, Glandular,Epithelial Cell, Squamous,Epithelial Cell, Transitional,Epithelial Cells, Adenomatous,Epithelial Cells, Glandular,Epithelial Cells, Squamous,Epithelial Cells, Transitional,Glandular Epithelial Cell,Squamous Cell,Squamous Epithelial Cell,Transitional Epithelial Cell
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D012333 RNA, Messenger RNA sequences that serve as templates for protein synthesis. Bacterial mRNAs are generally primary transcripts in that they do not require post-transcriptional processing. Eukaryotic mRNA is synthesized in the nucleus and must be exported to the cytoplasm for translation. Most eukaryotic mRNAs have a sequence of polyadenylic acid at the 3' end, referred to as the poly(A) tail. The function of this tail is not known for certain, but it may play a role in the export of mature mRNA from the nucleus as well as in helping stabilize some mRNA molecules by retarding their degradation in the cytoplasm. Messenger RNA,Messenger RNA, Polyadenylated,Poly(A) Tail,Poly(A)+ RNA,Poly(A)+ mRNA,RNA, Messenger, Polyadenylated,RNA, Polyadenylated,mRNA,mRNA, Non-Polyadenylated,mRNA, Polyadenylated,Non-Polyadenylated mRNA,Poly(A) RNA,Polyadenylated mRNA,Non Polyadenylated mRNA,Polyadenylated Messenger RNA,Polyadenylated RNA,RNA, Polyadenylated Messenger,mRNA, Non Polyadenylated
D014409 Tumor Necrosis Factor-alpha Serum glycoprotein produced by activated MACROPHAGES and other mammalian MONONUCLEAR LEUKOCYTES. It has necrotizing activity against tumor cell lines and increases ability to reject tumor transplants. Also known as TNF-alpha, it is only 30% homologous to TNF-beta (LYMPHOTOXIN), but they share TNF RECEPTORS. Cachectin,TNF-alpha,Tumor Necrosis Factor Ligand Superfamily Member 2,Cachectin-Tumor Necrosis Factor,TNF Superfamily, Member 2,TNFalpha,Tumor Necrosis Factor,Cachectin Tumor Necrosis Factor,Tumor Necrosis Factor alpha

Related Publications

Ning Ge, and Yasuhiko Nishioka, and Yoichi Nakamura, and Yoshio Okano, and Kazuo Yoneda, and Hirohisa Ogawa, and Akemi Sugita, and Hiroaki Yanagawa, and Saburo Sone
October 2002, Mediators of inflammation,
Ning Ge, and Yasuhiko Nishioka, and Yoichi Nakamura, and Yoshio Okano, and Kazuo Yoneda, and Hirohisa Ogawa, and Akemi Sugita, and Hiroaki Yanagawa, and Saburo Sone
October 2020, Nan fang yi ke da xue xue bao = Journal of Southern Medical University,
Ning Ge, and Yasuhiko Nishioka, and Yoichi Nakamura, and Yoshio Okano, and Kazuo Yoneda, and Hirohisa Ogawa, and Akemi Sugita, and Hiroaki Yanagawa, and Saburo Sone
February 2009, American journal of physiology. Lung cellular and molecular physiology,
Ning Ge, and Yasuhiko Nishioka, and Yoichi Nakamura, and Yoshio Okano, and Kazuo Yoneda, and Hirohisa Ogawa, and Akemi Sugita, and Hiroaki Yanagawa, and Saburo Sone
April 1999, The American journal of physiology,
Ning Ge, and Yasuhiko Nishioka, and Yoichi Nakamura, and Yoshio Okano, and Kazuo Yoneda, and Hirohisa Ogawa, and Akemi Sugita, and Hiroaki Yanagawa, and Saburo Sone
November 2017, Biochemical and biophysical research communications,
Ning Ge, and Yasuhiko Nishioka, and Yoichi Nakamura, and Yoshio Okano, and Kazuo Yoneda, and Hirohisa Ogawa, and Akemi Sugita, and Hiroaki Yanagawa, and Saburo Sone
June 2001, Inflammation research : official journal of the European Histamine Research Society ... [et al.],
Ning Ge, and Yasuhiko Nishioka, and Yoichi Nakamura, and Yoshio Okano, and Kazuo Yoneda, and Hirohisa Ogawa, and Akemi Sugita, and Hiroaki Yanagawa, and Saburo Sone
July 1995, British journal of pharmacology,
Ning Ge, and Yasuhiko Nishioka, and Yoichi Nakamura, and Yoshio Okano, and Kazuo Yoneda, and Hirohisa Ogawa, and Akemi Sugita, and Hiroaki Yanagawa, and Saburo Sone
May 2009, American journal of respiratory and critical care medicine,
Ning Ge, and Yasuhiko Nishioka, and Yoichi Nakamura, and Yoshio Okano, and Kazuo Yoneda, and Hirohisa Ogawa, and Akemi Sugita, and Hiroaki Yanagawa, and Saburo Sone
May 1983, Biochimica et biophysica acta,
Ning Ge, and Yasuhiko Nishioka, and Yoichi Nakamura, and Yoshio Okano, and Kazuo Yoneda, and Hirohisa Ogawa, and Akemi Sugita, and Hiroaki Yanagawa, and Saburo Sone
August 2002, The Journal of biological chemistry,
Copied contents to your clipboard!